Manal El-Sayed, MD, PhD

Manal H El-Sayed (MD, MSc and PhD Pediatrics)Ain Shams University, Egypt Dr. Manal El-Sayed (Cairo, Egypt) is Professor of Pediatrics at Ain Shams University, former Chair of the Pediatric Department, and founder and former director of the clinical research center (MASRI-CRC) and co-supervisor of the viral hepatitis treatment center at the Faculty of Medicine, Ain Shams University. She is also the clinical director of the national HCV Pediatric treatment program. Dr El-Sayed is a founding member of the Egyptian National Committee for Control of Viral Hepatitis (NCCVH) since 2006. She contributed to the establishment of a nationwide network of more than 100 specialized liver centers that provided interferon therapy and direct-acting antiviral agents for treatment of more than 4 million HCV patients. Manal collaborated on the development of the national action plan for prevention and control of viral hepatitis published in 2014 with representatives from WHO, US CDC, Pasteur Institute, and national stakeholders. In addition to co-supervising the nationwide mass screening program for adults and children reaching more than 65 million people.Manal is the secretary general of the Egyptian Liver Care Society, an NGO offering financial assistance to patients receiving hepatitis treatment or liver transplants as well as children with chronic liver disease. She authored, co-authored and reviewed numerous journal articles on liver disease, and participated in the development of the WHO's global HBV, HCV and diagnostic guidelines. Between 2011-2015, Manal was Vice Chair of WHO's Technical Advisory Group for Prevention and Control of Viral Hepatitis in Egypt and is a member of the Global Accelerator for Pediatric Formulations (GAP-f) and a WHO Strategic Technical Advisory Committee member for HIV, Viral Hepatitis and STIs. She was a board member of the European Study of Liver Disease International Liver Foundation (EILF) until 2023 and Governing Board member of the International Coalition for Elimination of hepatitis B (ICE-HBV) since 2020. She was appointed among the board of directors of the Global Hepatitis Fund (EndHep2030) until 2025. In addition to co-organising and co-chairing numerous international meetings on viral hepatitis and liver disease in Europe and Africa. Professor Manal is co-founder and President of the Society on Liver Disease in Africa, a sister society to international liver societies representing other continents. She received the State Merit Award for Advanced Science and Technology in 2022 and the International Liver Health Award in 2024. Professor El-Sayed has been appointed by HE the President of Egypt, among 28 experts and those with scientific and practical achievements and categories deemed necessary in accordance with the provisions of article 243 and 244 of the Constitution, as Member of House of Representatives in January 2026.